Cyacetacide

Cyacetacide

SCHEMBL678715

N#CCC(=O)NN

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9578015 0.74
SCHEMBL874014 0.74
SCHEMBL11589733 0.74
SCHEMBL28099171 0.74
SCHEMBL670466 0.74
SCHEMBL9202307 0.74 MCL1 (0.52)
SCHEMBL12489261 0.74
SCHEMBL47354 0.74
SCHEMBL6552951 0.72 KDM4E (0.40)
SCHEMBL8335317 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 835 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4615579-A1 ANTIGEN BINDING MOLECULES TARGETING SARS-COV-2 Generate Biomedicines, Inc. (US) 2025-09-17 EP claimed
EP-4580674-A2 ANTIGEN BINDING MOLECULES TARGETING PROGRAMMED CELL DEATH PROTEIN 1 (PD-1) Flagship Pioneering Innovations VI, LLC (US) 2025-07-09 EP claimed
EP-4519310-A1 ANTIGEN BINDING MOLECULES TARGETING SARS-COV-2 Generate Biomedicines, Inc. (US) 2025-03-12 EP claimed
WO-2024102674-A9 ANTIGEN BINDING MOLECULES TARGETING SARS-COV-2 GENERATE BIOMEDICINES, INC. (US) 2025-02-20 WO claimed
WO-2024219365-A1 NONAQUEOUS ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NONAQUEOUS-ELECTROLYTE CELL パナソニックIPマネジメント株式会社 2024-10-24 WO claimed
CN-118580150-A Preparation process of spermidine 福州大学至诚学院 2024-09-03 CN claimed
WO-2024050421-A2 ANTIGEN BINDING MOLECULES TARGETING PROGRAMMED CELL DEATH PROTEIN 1 (PD-1) FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) 2024-03-07 WO claimed
WO-2023215910-A1 ANTIGEN BINDING MOLECULES TARGETING SARS-COV-2 GENERATE BIOMEDICINES, INC. (US) 2023-11-09 WO claimed
EP-4252243-A2 NON-INVASIVE ASSESSMENT OF ALZHEIMER'S DISEASE Enigma Biointelligence, Inc. (CA) 2023-10-04 EP claimed
US-11398630-B2 Method of generating energy from a hydrazide containing anode fuel, and fuel cell IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2022-07-26 US claimed
EP-0743573-B1 Method for obtaining image contrast migration imaging members XEROX CORP (US) 2000-09-06 EP claimed
WO-2000034227-A1 PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) 2000-06-15 WO claimed
EP-0628547-B1 Process for the preparation of N-aminopyridones BASF AG (DE) 1997-09-24 EP claimed
EP-0743574-A2 Migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
EP-0743573-A2 Method for obtaining image contrast migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
US-5563014-A SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT XEROX CORPORATION (US) 1996-10-08 US claimed
US-5514505-A SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE XEROX CORPORATION (US) 1996-05-07 US claimed
US-5466812-A Reacting alkyl cyanoacetate with hydrazine; catalysis, phase transfer; lactamization, cyclization BASF AKTIENGESELLSCHAFT (DE) 1995-11-14 US claimed
EP-0450598-A2 Inhibitors of the advanced glycosylation of proteins and methods of use therefor THE ROCKEFELLER UNIVERSITY (US) 1991-10-09 EP claimed
US-4101658-A Antibacterial hydrazono cephalosporins SHIONOGI & CO., LTD. (JP) 1978-07-18 US claimed